1. ALLA AKTIER
  2. NYHETER
  3. MENDUS

Mendus

Nyheter Mendus Nyheter alla bolag
Hej Visste du att du med vår premiumtjänst får fullständig historik i alla grafer, pressmeddelanden och andra notiser för dina favoritbolag direkt som DM i Discord samt en del andra godsaker? Du slipper dessutom störande annonser på sajten. Testa gratis i 14 dagar!

Invitation to first quarter financial report and business update

Mendus AB (“Mendus” publ; IMMU.ST), will publish its interim report for the first quarter 2025 on May 6 at 08.00 CEST. The company will host a live presentation and business update on the same day at 14.00 CEST. The presentation will be held in English and includes a Q&A session.

Date and time: May 6 at 14.00 CEST

If you wish to participate via webcast please use the link below.
https://mendus.events.inderes.com/q1-report-2025

If you wish to participate and ask questions via teleconference, please register on the link below. After registration you will be provided phone numbers and a conference ID to access the conference.
https://conference.inderes.com/teleconference/?id=50052314

For more information, please contact:
Erik Manting
Chief Executive Officer
E-mail: ir@mendus.com

About Mendus AB (publ)

Mendus is dedicated to changing the course of cancer treatment by addressing tumor recurrence and improving long-term survival for cancer patients, while preserving health and quality of life. We leverage our understanding of dendritic cell biology to develop an advanced clinical pipeline of immunotherapies which combine clinical efficacy with a benign safety profile. Based in Sweden and The Netherlands, Mendus is publicly traded on the Nasdaq Stockholm under the ticker IMMU.ST. https://www.mendus.com/

Attachments
Invitation to Q1 2025 report

Datum 2025-04-29, kl 08:00
Källa MFN
Bifogade filer
Invitation to Q1 2025 report